Focusing on cell lines with heterozygous mutations, we found that six pan-cancer missense mutational cancer genes (TP53, KRAS, BRAF, CTNNB1, PIK3CA and LRP1B) remained significant hits when we only considered cell lines with homozygous deletions. This evidence concerns the gene BRAF and cancer.